Breaking News
Sort by:
Top Post
Google Cloud Launches AI-powered Solutions to Safely Accelerate Drug Discovery and Precision Medicine
Google Cloud has announced two new AI-powered life sciences solutions to accelerate drug discovery and […]
FSD Pharma Receives Regulatory Clearance for Its Proposed Phase-1 Clinical Trial of Lucid-21-302 (Lucid-MS), First-in-Class Multiple Sclerosis Drug Candidate
FSD Pharma, a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech […]
Roche Announces Positive Data from Global Phase III Programme for Crovalimab in PNH, a Rare Life-threatening Blood Condition
Roche has announced positive results from the global phase III COMMODORE 2 study, evaluating the […]
Sandoz Biologics License Application for Proposed Biosimilar Denosumab Accepted by US FDA
Sandoz, a global leader in off-patent (generic and biosimilar) medicines, today announced that the US […]
Egret Therapeutics Receives FDA Clearance of IND Application for EGT 101 for Treatment of Delayed Cerebral Ischemia
Egret Therapeutics, a clinical-stage biotechnology company focused on developing transformative therapies for neurological conditions, has […]
Orexo Submits New Drug Application to FDA for OX124, a High-dose Rescue Medication for Opioid Overdose
Orexo AB announces the submission of a New Drug Application (NDA) to the US Food and […]
Jesduvroq Approved by US FDA for Anaemia of Chronic Kidney Disease in Adults on Dialysis
GSK today announced that the US Food and Drug Administration (FDA) has approved Jesduvroq (daprodustat), […]
Genoscience Pharma receives FDA Orphan Drug Designation for ezurpimtrostat to treat HepatoCellular Carcinoma (HCC)
Genoscience Pharma, a clinical-stage biotech company developing unique lysosomotropic drug candidates for the treatment of […]
Ionis receives FDA Fast Track designation for Olezarsen in patients with Familial Chylomicronemia Syndrome
Ionis Pharmaceuticals today announced that the United States Food and Drug Administration (FDA) has granted […]
Xeris Biopharma Announces FDA Grants Orphan-drug Exclusivity for Recorlev
Xeris Biopharma, a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing […]
Alpha Biopharma Submits New Drug Application for NSCLC Patients with CNS Metastases
Alpha Biopharma, a developer of innovative drugs, announces that the Center for Drug Evaluation (CDE) […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more